Beyond resorption-driven coupling: a multi-layered framework for osteoclast-osteoblast communication and its...

Skeletal homeostasis depends on tightly coordinated communication between osteoclasts and osteoblasts, yet the molecular logic governing this coupling remains incompletely understood. This review reframes the osteoclast-osteoblast relationship by integrating developmental biology, molecular signaling, and translational perspectives into a unified analytical framework. We first trace the developmental origins of osteoclasts across embryonic hematopoietic waves, presenting evidence that ontogenetic heterogeneity-rather than being a developmental relic-actively shapes the coupling capacity of osteoclast populations throughout life. We then examine the hierarchical differentiation cascade of the osteoblast lineage, emphasizing how the adipo-osteo switch and hormonal regulation at each differentiation stage create multiple points of vulnerability and therapeutic opportunity. A central argument of this review is that pre-osteoclasts function as major, and potentially dominant, coupling effectors in bone remodeling. Operating through a secretome that includes sphingosine-1-phosphate, PDGF-BB, and afamin, these mononuclear precursors coordinate osteoblast recruitment and vascularization independently of bone resorption. However, the relative contribution of pre-osteoclast-derived signals versus other coupling mechanisms likely varies by skeletal site, age, and pathological context. We systematically dissect three core signaling cascades-BMP, sphingolipid/sclerostin, and WNT-and argue that their functional convergence creates a robust yet tunable communication network. We further evaluate recently identified coupling factors including cardiotrophin-1, SLIT3, C3a, and CTHRC1, alongside surface-mediated and vesicle-based communication systems. Finally, we critically assess current therapeutic strategies through the lens of coupling biology, proposing that the persistent failure to develop truly disease-modifying skeletal therapies stems from an incomplete appreciation of the multi-layered nature of osteoclast-osteoblast communication. Collectively, this review establishes that the anabolic and resorptive functions of the osteoclast lineage are mechanistically separable and proposes that therapeutic strategies aimed at expanding the coupling-competent pre-osteoclast pool-rather than broadly suppressing or stimulating remodeling-represent a paradigm shift toward next-generation skeletal therapies that preserve, rather than disrupt, the endogenous coupling network.